Key Takeaways
- A differential pressure (diastolic BP – ICP) >30 mmHg is a moderate‑strength recommendation for ruling out ACS.
- Biomarkers such as femoral vein lactate (during embolectomy) have moderate support; myoglobinuria and troponin are limited.
- Timely fasciotomy remains the definitive treatment to avoid irreversible ischemia and long‑term disability.
- The guideline warns against using fasciotomy as a surrogate diagnosis, reducing medicolegal bias.
- Implementation of standardized diagnostic criteria can halve hospital stay lengths and lower overall healthcare costs.
The High-Stakes Reality of Acute Compartment Syndrome
As orthopaedic trauma surgeons, we operate under the axiom that "time is tissue." Acute Compartment Syndrome (ACS) represents one of our most demanding diagnostic and therapeutic challenges. Pathophysiologically, ACS occurs when the pressure within a closed osteofascial compartment rises to a level that compromises myoneural capillary blood flow. Whether triggered by high-energy trauma, ischemia-reperfusion events, or low-energy crush injuries, the result is the same: once metabolic demands are no longer met, irreversible neuromuscular ischemia and necrosis ensue, culminating in permanent neural deficits and ischemic contractures.
The burden of a missed diagnosis is catastrophic for both the patient and the healthcare system. Patients with tibia fractures complicated by ACS face hospital stays that are more than double the average, with total charges two to three times greater. Long-term quality-of-life data (EQ-5D) reveals that these patients suffer persistent issues with chronic pain, swelling, and significantly decreased endurance for years post-injury.
Our military colleagues have long understood these stakes. In a sample of over 17,000 casualties, survival rates demonstrated a "V-shaped" reversal that was temporally associated with the implementation of formal training programs on tourniquet usage and fasciotomy. In the modern era of "prolonged field care," where medical skill maintenance is a priority in low-volume, austere environments, these evidence-based guidelines serve as a vital repository of institutional knowledge to prevent the degradation of surgical lessons learned on the battlefield.
The Diagnostic Dilemma: Treatment vs. Diagnosis
A defining challenge in our field is that we lack standard diagnostic criteria for ACS. This ambiguity leads to significant variation in clinical practice. Historically, the performance of a fasciotomy has been used as a surrogate for the diagnosis of ACS in academic literature—an association that is fundamentally flawed. Academic weight from investigators like O’Toole (2009) and Bhattacharyya (2004) highlights how the fear of a missed case, coupled with immense medicolegal pressure, creates a systemic bias toward surgical intervention even when the diagnosis is questionable.
The 2025 AAOS work group provides a stark warning regarding this bias:
"The therapeutic performance of decompressive fasciotomy is used in many papers as a surrogate for the diagnosis of acute compartment syndrome, despite the fact that they are not the same thing... there is certainly a bias towards doing fasciotomy in order to avoid medical and medicolegal complications associated with a missed or delayed diagnosis."
Modern Diagnostic Tools: Beyond the Physical Exam
Biomarkers: Procedural Context and Limitations
The 2025 update incorporates biochemical markers into the diagnostic algorithm, though they must be interpreted with caution. A critical detail for the surgeon: femoral vein lactate is specifically recommended when sampled during surgical embolectomy for acute vascular ischemia.
| Biomarker | Target Population | Strength of Recommendation |
|---|---|---|
| Myoglobinuria | Traumatic lower extremity injury | Limited |
| Serum Troponin | Traumatic lower extremity injury | Limited |
| Femoral Vein Lactate | Acute vascular ischemia (during embolectomy) | Moderate |
| Myoglobinuria | High-voltage electrical injury | Limited (Does Not Assist) |
Pressure Monitoring: The Temporal Aspect
The guideline provides a Moderate recommendation for intracompartmental pressure (ICP) monitoring. The gold standard remains the differential pressure: Diastolic Blood Pressure minus Intracompartmental Pressure (DBP-ICP).
A threshold of >30 mmHg is a robust tool to assist in ruling out ACS. However, a single reading is insufficient for a definitive diagnosis. Drawing from the McQueen studies, we emphasize a "2-hour consecutive threshold." Continuous or serial monitoring is essential to confirm that perfusion pressure is sustained above the danger zone, as transient spikes may lead to unnecessary fasciotomies.
Special Cases: The Unreliable Exam
- Obtunded Patients: In patients with altered mental status where a clinical exam is impossible, the work group recommends repeated or continuous ICP measurements as a primary diagnostic tool.
- Neuraxial Anesthesia: Regional blocks can mask the "pain out of proportion" that we rely on. If neuraxial anesthesia is utilized, the trauma team must maintain a high index of suspicion, employing frequent physical examinations and/or pressure monitoring to avoid the "never-event" of a delayed diagnosis.
Surgical Management and the 2025 Technical Updates
Fasciotomy Technique
The consensus remains that the choice between a single or dual-incision leg fasciotomy is secondary to the primary goal: achieving complete decompression of all affected compartments. The 2023 Türkiye earthquake study (Barça et al.) reinforces that in disaster or mass-casualty settings, the priority must remain the thoroughness of the decompression rather than the specific technical approach.
Associated Fractures: A Major Evidence Upgrade
One of the most significant changes in the 2025 update is the upgrade from Consensus to Limited evidence regarding the management of fractures associated with ACS. We now recommend that operative fixation (internal or external) be performed for the initial stabilization of long bone fractures when a concomitant fasciotomy is required. This shift reflects a growing body of evidence suggesting that stabilizing the "skeleton" of the limb facilitates better soft-tissue management.
Wound Care
Managing the soft-tissue envelope after decompression is critical. Limited evidence supports the use of Negative Pressure Wound Therapy (NPWT) to manage fasciotomy wounds. NPWT has been shown to reduce the time to definitive wound closure and decrease the requirement for skin grafting, which correlates directly with improved self-rated health status in the recovery phase.
The "Never-Event": Navigating Late or Missed ACS
Perhaps the highest level of clinical judgment is required when a patient presents with a "missed" compartment syndrome. The 2025 guideline is explicit: fasciotomy is not indicated when there is evidence of irreversible neuromuscular or vascular damage.
Opening a necrotic compartment is a "never-event" that introduces catastrophic risks, including significant infection and systemic rhabdomyolysis. In these tragic scenarios, the surgeon should utilize external fixation or casting—techniques that stabilize the fracture without violating the affected compartment—to avoid further patient morbidity.
Conclusion: Actionable Takeaways for the Trauma Team
The 2025 AAOS updates refine our approach to ACS by shifting away from surrogate measures toward physiologically-based logic:
- Prioritize Differential Pressure: Utilize the DBP-ICP >30 mmHg threshold to rule out ACS, but rely on serial or continuous data over a 2-hour window rather than a snapshot.
- Contextualize Biomarkers: Use femoral vein lactate specifically during embolectomy for vascular cases and troponin/myoglobinuria as supplementary data in trauma.
- Stabilize Fractures Operatively: In a major update, the guideline now supports initial internal or external fixation during the same session as the fasciotomy.
- Manage Wounds Proactively: Use NPWT to expedite closure and minimize the need for grafting.
- Exercise Surgical Restraint: Recognize when a compartment is already lost. Avoiding fasciotomy in necrotic tissue is a mark of clinical maturity and prevents systemic complications.
Future Research Directions The "holy grail" of ACS research remains the development of diagnostic tests that can reliably distinguish between reversible ischemia and irreversible necrosis. Until such physiologically-based tests are standardized, our clinical judgment, informed by these guidelines, remains the patient's best defense.
Guideline Reference & Access
Please cite this guideline as the: American Academy of Orthopaedic Surgeons Management of Acute Compartment Syndrome Evidence-Based Clinical Practice Guideline.
The full update, including the Rapid Update Methodology and the OrthoGuidelines web-based app, can be accessed at www.orthoguidelines.org.